Kunming Longjin Pharmaceutical Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 3/6
Kunming Longjin Pharmaceutical has a total shareholder equity of CN¥528.6M and total debt of CN¥1.0M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are CN¥597.4M and CN¥68.8M respectively.
Anahtar bilgiler
0.2%
Borç/özkaynak oranı
CN¥1.00m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | CN¥303.19m |
| Eşitlik | CN¥528.62m |
| Toplam yükümlülükler | CN¥68.75m |
| Toplam varlıklar | CN¥597.37m |
Son finansal sağlık güncellemeleri
Recent updates
What Kunming Longjin Pharmaceutical Co., Ltd.'s (SZSE:002750) 38% Share Price Gain Is Not Telling You
Aug 14
Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) May Have Run Too Fast Too Soon With Recent 40% Price Plummet
Jun 30Risks Still Elevated At These Prices As Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) Shares Dive 26%
Apr 26We're Not Very Worried About Kunming Longjin Pharmaceutical's (SZSE:002750) Cash Burn Rate
Apr 17Revenues Not Telling The Story For Kunming Longjin Pharmaceutical Co., Ltd. (SZSE:002750) After Shares Rise 29%
Mar 08Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 002750's short term assets (CN¥354.6M) exceed its short term liabilities (CN¥42.0M).
Uzun Vadeli Yükümlülükler: 002750's short term assets (CN¥354.6M) exceed its long term liabilities (CN¥26.7M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 002750 has more cash than its total debt.
Borcun Azaltılması: 002750's debt to equity ratio has increased from 0% to 0.2% over the past 5 years.
Borç Kapsamı: 002750's operating cash flow is negative, therefore debt is not well covered.
Faiz Kapsamı: Insufficient data to determine if 002750's interest payments on its debt are well covered by EBIT.